EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distinct chemical structures inhibit the CEMIP hyaluronidase and promote oligodendrocyte progenitor cell maturation

Alec Peters, Fatima Banine, Kanon Yasuhara, Angela Hoffman, Basappa, Prashant K Metri, Lily Gunning, Ava Huffman, Jake VanCampen, Clinton C Shock, Stephen A Back, Larry S Sherman

Journal of Biological Chemistry · 2024-12 · 300 (12) · 107916

DOI: 10.1016/j.jbc.2024.107916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024-12. Verfasst von Alec Peters und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon, USA; Department of Cell, Developmental and Cancer Biology, Oreg…. Hauptthemen laut MEDLINE: Oligodendrocyte Precursor Cells, Hyaluronoglucosaminidase. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growing evidence supports pathogenic roles for chronically elevated hyaluronidase activity in numerous conditions. Elevated expression of one such hyaluronidase, the Cell Migration Inducing and hyaluronan binding Protein (CEMIP), has been implicated in the pathogenesis and progression of several cancers as well as demyelinating diseases in the central nervous system (CNS). Developing effective and selective CEMIP inhibitors could therefore have efficacy in treating a variety of conditions where CEMIP is chronically elevated. Using two distinct screens for novel hyaluronidase inhibitors, we identified two synthetic thiocarbamates and one plant-derived flavonoid, sulfuretin, that effectively blocked CEMIP activity in live cells, including a tumorigenic cell line and primary cultures of oligodendrocyte progenitor cells (OPCs). None of these agents influenced cell proliferation, but they had differential dose-dependent and cell type-specific effects on cell survival. Furthermore, we found that each of these agents could promote oligodendrocyte maturation by OPCs in the presence of high molecular weight (>2 Mda) hyaluronan, the accumulation of which is linked to the inhibition of OPC maturation and remyelination failure in demyelinating diseases. These findings indicate that CEMIP can be inhibited through distinct chemical interactions and that CEMIP inhibitors have potential efficacy for treating demyelinating diseases or other conditions where CEMIP is elevated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oligodendrocyte Precursor CellsHyaluronoglucosaminidaseHumansAnimalsHyaluronic AcidRatsOligodendrogliaCell DifferentiationThiocarbamatesCell ProliferationEnzyme Inhibitors

Stichwörter der Autor:innen

CEMIPflavonoidshyaluronanhyaluronidaseoligodendrocytessulfuretin

Substanzen

HyaluronoglucosaminidaseCEMIP protein, humanHyaluronic AcidThiocarbamatesEnzyme Inhibitors

Autor:innen und Institutionen

  • Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon, USA; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon, USA.
  • Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon, USA.
  • Department of Chemistry, University of Portland, Portland, Oregon, USA.
  • Department of Studies in Organic Chemistry, University of Mysore, Manasagangotri, India.
  • College of Agricultural Sciences, Oregon State University, Corvallis, Oregon, USA.
  • Departments of Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon, USA.

Förderung

  • NINDS NIH HHS
  • NIH HHS
  • NIA NIH HHS
  • NIAAA NIH HHS
  • National Multiple Sclerosis Society
  • National Institute of Neurological Disorders and Stroke
  • Congressionally Directed Medical Research Programs
  • National Institutes of Health Office of the Director

Zitieren

APA

Peters, A., Banine, F., Yasuhara, K., Hoffman, A., Basappa, Metri, P. K., Gunning, L., Huffman, A., VanCampen, J., Shock, C. C., Back, S. A., & Sherman, L. S. (2024). Distinct chemical structures inhibit the CEMIP hyaluronidase and promote oligodendrocyte progenitor cell maturation. Journal of Biological Chemistry, 300(12), 107916. https://doi.org/10.1016/j.jbc.2024.107916

Vancouver

Peters A, Banine F, Yasuhara K, Hoffman A, Basappa, Metri PK, et al. Distinct chemical structures inhibit the CEMIP hyaluronidase and promote oligodendrocyte progenitor cell maturation. Journal of Biological Chemistry. 2024;300(12):107916. doi:10.1016/j.jbc.2024.107916

BibTeX
@article{Peters2024,
  author = {Peters, Alec and Banine, Fatima and Yasuhara, Kanon and Hoffman, Angela and Basappa and Metri, Prashant K and Gunning, Lily and Huffman, Ava and VanCampen, Jake and Shock, Clinton C and Back, Stephen A and Sherman, Larry S},
  title = {Distinct chemical structures inhibit the CEMIP hyaluronidase and promote oligodendrocyte progenitor cell maturation},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  volume = {300},
  number = {12},
  pages = {107916},
  doi = {10.1016/j.jbc.2024.107916}
}
Kostenlos starten →